Crossmark

Exploring anti-corruption, transparency, and accountability in the World Health Organization, the United Nations Development Programme, the World Bank Group, and the Global Fund to Fight AIDS, Tuberculosis and Malaria

Crossref DOI link: https://doi.org/10.1186/s12992-020-00629-5

Published Online: 2020-10-20

Published Print: 2020-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Kohler, Jillian Clare

Bowra, Andrea
Funding

Funding for this research was provided by:

Leslie Dan Faculty of Pharmacy, University of Toronto (000000)
License Information

Text and Data Mining valid from 2020-10-20

Version of Record valid from 2020-10-20
More Information

Article History

Received: 26 July 2020

Accepted: 7 October 2020

First Online: 20 October 2020

Ethics approval and consent to participate

: Not applicable.

: Not applicable.

: Dr. Jillian Clare Kohler is the Director of the WHO Collaborating Centre for Governance, Accountability, and Transparency in the Pharmaceutical Sector, which is not a competing interest but should be noted given the topic.

Document is current

Any future updates will be listed below